News Search

The program prioritized applications that focused on promoting health equity and racial justice.

Fewer than half of ischemic stroke patients whom guidelines say should get dual-antiplatelet therapy (DAPT) actually receive the treatment, a new study suggests.

Dr. Andrews, the director of neuromuscular clinical trials at CUIMC, shared her perspective on the challenges of familiarizing oneself with the influx of novel medications for neuromuscular diseases.

Please join in welcoming Ewa Koziorynska, MD to our faculty, as an assistant professor of neurology at CUIMC, in the Division of Epilepsy and Sleep.